# Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia

> **NCT01017614** · PHASE3 · COMPLETED · sponsor: **Pharmacosmos A/S** · enrollment: 350 (estimated)

## Conditions studied

- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Monofer
- **DRUG:** Iron Sulphate

## Key facts

- **NCT ID:** NCT01017614
- **Lead sponsor:** Pharmacosmos A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2012-07
- **Final completion:** 2012-08
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2012-11-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01017614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01017614, "Iron Oligosaccharide in Inflammatory Bowel Disease Subjects With Iron Deficiency Anaemia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01017614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*